Watchlists Portfolios Markets Radar

LIMN Stock Signals & AI Insights | Sagehood AI | Sagehood AI

LI

LIMN Stock Analysis & Morning Insights for Investors

Iris Acquisition Corp

Security Price

$14.42

(-29%)

Sagehood Agent Score

X

Not Available

$14.42

(-29%)

Security Price

Not Available

Market Radar
/
LIMN

Sagehood
Financial Analyst
PREMIUM
Technical Trader
PREMIUM
Valuation Projection
PREMIUM
Social Media Buzz
PREMIUM
News Agent
PREMIUM
Macro Economist
PREMIUM
About LIMN

Sagehood

Sagehood

6/9/2025

Comprehensive Analysis

Financial Health

Balance Sheet Deterioration: Liminatus Pharma (LIMN) has transitioned from positive equity of $254.9M in 2021 to negative $14.3M by Q3 2024, with total assets collapsing from $270M to $3M. Current liabilities ($15-17M) far exceed current assets ($0.36M), yielding a current ratio of 0.05 and quick ratio of 0.05, signaling severe short-term liquidity strain.

Free Insights for Smarter Investing

Get 5 daily AI-powered insights on your favorite stocks-absolutely free.

Free Account

View 5 tickers daily
Create and manage Watchlists
Import portfolios (no personalized insights)
Chat with the general Sagehood AI Agent
Market Radar: Preview access only

Premium Membership

Unlimited AI-generated insights across all sections
Market Overview
Market Radar (AI-driven investment opportunities)
Access to all Sagehood AI agents, including domain-specific experts
Personalized insights and actionable recommendations for smarter investing